Mr. Speaker, the meeting yesterday with Industry Canada was crucial for the unemployed researchers from BioChem Pharma.
As proof, Shire's head of finance came from London in preparation for negotiations with Ottawa.
Can the Minister of Industry tell us if he ensured that the revitalization of BioChem Pharma would be part of the agreement with Shire to compensate for the closing of this laboratory and save several dozen jobs in research?